These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7286562)

  • 1. Antibody dependent cellular cytotoxicity in chronic active liver diseases.
    Kakumu S; Hotta R; Kuriki J
    Gastroenterol Jpn; 1981; 16(4):372-6. PubMed ID: 7286562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro morphological studies on antibody-dependent nonimmune lymphocyte-mediated cytotoxicity in chronic active liver disease.
    Kawanishi H
    Am J Dig Dis; 1978 Feb; 23(2):97-109. PubMed ID: 341690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.
    Eggink HF; Houthoff HJ; Huitema S; Gips CH; Poppema S
    Clin Exp Immunol; 1982 Oct; 50(1):17-24. PubMed ID: 6983407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro studies on IgG-mediated lymphocyte cytotoxicity in chronic active liver disease.
    Kawanishi H
    Gastroenterology; 1977 Sep; 73(3):549-55. PubMed ID: 892355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of suppressor T cell function and circulating immune complexes in chronic active liver diseases.
    Hotta R; Kuriki J; Kakumu S
    Clin Exp Immunol; 1981 Nov; 46(2):375-81. PubMed ID: 6461458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody dependent cellular cytotoxicity (ADCC) in acute hepatitis B and in chronic active hepatitis.
    Bortolotti F; Realdi G; Diodati G; Fattovich G
    Clin Exp Immunol; 1978 Aug; 33(2):211-6. PubMed ID: 719950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous cell-mediated (SCMC) and antibody-dependent cellular cytotoxicity (ADCC) in patients with acute and chronic active hepatitis.
    Hütteroth TH; Poralla T; Meyer zum Büschenfelde KH
    Klin Wochenschr; 1981 Jun; 59(12):699-706. PubMed ID: 6454806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.
    Vierling JM; Nelson DL; Strober W; Bundy DM; Jones EA
    J Clin Invest; 1977 Nov; 60(5):1116-28. PubMed ID: 332716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody dependent cytotoxicity in chronic active liver disease.
    Banciu T; Arcan P
    Gastroenterol Jpn; 1988 Dec; 23(6):695-7. PubMed ID: 3220246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of antibody-dependent cellular cytotoxicity by artificial immune complexes and pathological sera.
    Howat JM; Moore M; Hilton AM; Kimber I
    Immunology; 1979 Jun; 37(2):467-75. PubMed ID: 468310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of lymphocyte cytotoxicity in chronic active hepatitis.
    Kakumu S; Hara T; Gohji H; Sakamoto N
    Clin Exp Immunol; 1978 Jul; 33(1):71-8. PubMed ID: 709913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte cytotoxicity and inhibition studied with autologous liver cells: observations in chronic active liver disease and the primary biliary cirrhosis syndrome.
    Geubel AP; Keller RH; Summerskill WH; Dickson ER; Tomasi TB; Shorter RG
    Gastroenterology; 1976 Sep; 71(3):450-6. PubMed ID: 950096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K-cell-mediated antibody-dependent cellular cytotoxicity in chronic active liver disease.
    Kawanishi H; MacDermott RP
    Gastroenterology; 1979 Jan; 76(1):151-8. PubMed ID: 361492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on circulating soluble immune complexes of the liver disease. 6. Comparative studies of 125I-pRF inhibition assay, 125I-Clq inhibition assay and 125I-Clq binding assay.
    Narumoto J
    Gastroenterol Jpn; 1981; 16(2):174-85. PubMed ID: 6971771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of circulating immune complexes in chronic hepatopathies].
    Delsignore R; Baroni MC; Mineo F; Conversi E; Campana G; Butturini U
    G Clin Med; 1984; 65(9-10):389-94. PubMed ID: 6530118
    [No Abstract]   [Full Text] [Related]  

  • 16. [Circulating immune complexes in patients with acute and chronic diseases of the liver].
    Uibo RM; Nutt HR; Prjukk TJ
    Ter Arkh; 1989; 61(2):61-4. PubMed ID: 2524905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of lymphocytes mediating antibody-dependent cell-mediated cytotoxicity in patients with chronic active hepatitis.
    Nonomura A; Ohta G; Kobayashi K; Kato Y
    Tohoku J Exp Med; 1981 Sep; 135(1):63-77. PubMed ID: 7324051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH).
    Warnatz H; Rösch W; Gerlich W; Gutmann W
    Clin Exp Immunol; 1979 Jan; 35(1):133-40. PubMed ID: 371882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of circulating HBs antigen-antibody immune complexes in patients with HBs antigen-positive liver disease.
    Sugiura K; Hasumura Y; Takeuchi J
    Gastroenterol Jpn; 1982; 17(3):241-5. PubMed ID: 7117781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on circulating immune complexes of the liver disease. 4. Clq binding activity.
    Arima T; Narumoto J; Shimomura H; Suwaki K; Kunishi K; Yasuhara T; Nagashima H
    Gastroenterol Jpn; 1980; 15(1):27-32. PubMed ID: 6153628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.